Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Globeimmune, Inc. (GBIM) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2016-03-31.
| Income Statement Financials | |
$0.94M |
|
$-0.86M |
|
$0.51M |
|
$0.43M |
|
$1.80M |
|
$-0.86M |
|
-- |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.84M |
|
5.75M |
|
5.75M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$9.45M |
|
$0.19M |
|
$0.32M |
|
$9.77M |
|
$4.14M |
|
-- |
|
$3.48M |
|
$7.62M |
|
$2.15M |
|
$2.15M |
|
$2.15M |
|
5.75M |
|
| Cash Flow Statement Financials | |
$-1.21M |
|
-- |
|
-- |
|
$9.90M |
|
$8.69M |
|
$-1.21M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.28 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
45.40% |
|
-91.46% |
|
-91.46% |
|
-- |
|
-91.46% |
|
-91.46% |
|
$-1.21M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-40.10% |
|
-40.10% |
|
-8.82% |
|
-40.10% |
|
$0.37 |
|
$-0.21 |
|
$-0.21 |
|